Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Le Doan, T
   Cell binding and internalisation of oligonucleotides
   STP PHARMA SCIENCES
   
   T. Le Doan, "Cell binding and internalisation of oligonucleotides", STP PHARM S, 11(1), 2001, pp. 75-82
2. Meunier, L; Monsigny, M; Roche, AC
   Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation
   ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
   
   L. Meunier et al., "Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation", ANTISENSE N, 11(2), 2001, pp. 117-123
3. Pichon, C; Roufai, MB; Monsigny, M; Midoux, P
   Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides
   NUCLEIC ACIDS RESEARCH
   
   C. Pichon et al., "Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides", NUCL ACID R, 28(2), 2000, pp. 504-512
4. Pichon, C; Monsigny, M; Roche, AC
   Intracellular localization of oligonucleotides: Influence of fixative protocols
   ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
   
   C. Pichon et al., "Intracellular localization of oligonucleotides: Influence of fixative protocols", ANTISENSE N, 9(1), 1999, pp. 89-93
5. Flanagan, WM; Wagner, RW; Grant, D; Lin, KY; Matteucci, MD
   Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide
   NATURE BIOTECHNOLOGY
   
   W.M. Flanagan et al., "Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide", NAT BIOTECH, 17(1), 1999, pp. 48-52